Figure 1 summarizes the comparison between G-test, AFP and AAR levels for HCC, versus healthy (Fig. 1 A-C), CH (Fig. 1D-F), and LC (Fig. 1G-I) patient groups. This evidence concerns the gene AFP and hepatocellular carcinoma.